Analysis of Dopamine D2 Receptor (DRD2) Gene Polymorphisms in Cannabinoid Addicts

Journal of Forensic Sciences

Volumn 57, Issue 6, 2012, Pages 1621-1624

  Nacak, Muradiye ^a   Isir, Aysun B ^a   Balci, Sibel O ^a   Pehlivan, Sacide ^a   Benlier, Necla ^a   Aynacioglu, Sukru ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Cannabis; DNA polymorphism; Dopamine receptor gene; Forensic science; Polymerase chain reaction; Taq1 polymorphism

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANNABIS ADDICTION; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; TURKEY; YOUNG ADULT;

EID: 84868201125     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2012.02169.x     Document Type: Article

References (39)

1. Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000;57(3):261-9.
2. Grove WM, Eckert ED, Heston L, Bouchard TJ Jr, Segal N, Lykken DT. Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol Psychiatry 1990;27(12):1293-304.
3. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001;24(2):97-129.
4. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988;242(4879):715-23.
5. Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 2007;62(6):616-26.
6. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 2009;20(1):1-17.
7. Shahmoradgoli Najafabadi M, Ohadi M, Joghataie MT, Valaie F, Riazalhosseini Y, Mostafavi H, et al.Association between the DRD2 A1 allele and opium addiction in the Iranian population. Am J Med Genet B Neuropsychiatr Genet 2005;134B(1):39-41.
8. Baransel Isir AB, Oguzkan S, Nacak M, Gorucu S, Dulger HE, Arslan A. The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence. Am J Forensic Med Pathol 2008;29(4):320-2.
9. Noble EP. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 1998;16(1):33-45.
10. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, et al.The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989;45(5):778-85.
11. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics 1991;10(3):527-30.
12. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 1995;5(3):121-41.
13. Hamajima N, Ito H, Matsuo K, Saito T, Tajima K, Ando M, et al.Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study. J Epidemiol 2002;12(4):297-304.
14. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood RC, et al.Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993;33(3):271-85.
15. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, et al.Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992;49(9):723-7.
16. Karaoguz MY, Sahin FS, Onen I, Cosar B, Arikan Z, Menevse A. Lack of association between TaqIA RFLP of the dopamine D2 receptor gene and alcoholism in type II Turkish alcoholics. Korean J Genetic 2004;26(2):149-54.
17. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y, et al.Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 1995;57(6):1445-56.
18. Noble EP, Zhang X, Ritchie TL, Sparkes RS. Haplotypes at the DRD2 locus and severe alcoholism. Am J Med Genet 2000;96(5):622-31.
19. Gelernter J, Kranzler H. D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacology 1999;20(6):640-9.
20. Behravan J, Hemayatkar M, Toufani H, Abdollahian E. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population. Arch Iran Med 2008;11(3):252-6.
21. Lee JF, Lu RB, Ko HC, Chang FM, Yin SJ, Pakstis AJ, et al.No association between DRD2 locus and alcoholism after controlling the ADH and ALDH genotypes in Chinese Han population. Alcohol Clin Exp Res 1999;23(4):592-9.
22. Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY, et al.Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease. Mov Disord 2003;18(5):593-5.
23. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Ozkaragoz T, et al.Genetic predisposition in alcoholism: association of the D2 dopamine receptor Taql B1 RFLP with severe alcoholics. Alcohol 1993;10(1):59-67.
24. Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD, et al.The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogenomics J 2007;7(4):266-74.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: The American Psychiatric Association, 1994.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res 1988;16:12-15.
27. Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, et al.The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease. Mov Disord 2000;5:127-31.
28. 9-tetrahydrocannabivarin. Br J Pharmacol 2008;153(2):199-215.
29. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346(6284):561-4.
30. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365(6441):61-5.
31. Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 2003;84(4):698-704.
32. Hartman CA, Hopfer CJ, Haberstick B, Rhee SH, Crowley TJ, Corley RP, et al.The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Drug Alcohol Depend 2009;104(1-2):11-16.
33. 1 opioid receptor mechanism. Science 1997;276(5321):2048-50.
34. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003;116B(1):103-25.
35. Blum K, Noble EP, Sheridan PJ, Finley O, Montgomery A, Ritchie T, et al.Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 1991;8(5):409-16.
36. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 1994;34(3):175-80.
37. Barratt DT, Coller JK, Somogyi AA. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments. Am J Med Genet B Neuropsychiatr Genet 2006;141B(4):323-31.
38. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, et al.D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997;7(6):479-84.
39. Bice PJ, Liang T, Zhang L, Strother WN, Carr LG. DRD2 expression in the high alcohol-preferring and low alcohol-preferring mice. Mamm Genome 2008;19(2):69-76.